Dr. Ryan Hartwell, Ph.D.
Dr. Hartwell, an entrepreneur with a strong record of successful business startups, is a co-inventor of FS2 and AI-001 cell therapy. Prior to undertaking his Ph.D., he cofounded ATS Biotech Inc., an advanced, biomedical wound care (medical device) company specializing in the development and manufacture of medical devices that are currently being manufactured in the United States. As a university and workshop lecturer with first-hand experience in FDA, EU, HC, CFDA and Japan Regulatory filings for drug products, medical devices and natural health products, Dr. Hartwell brings a wealth of experience to Mind Cure’s regulatory affairs and product research. Dr. Hartwell received his Ph.D. in Experimental Medicine at UBC, receiving the
Vancouver Coastal Health Research Institute Award for Top Graduating Doctoral Student and Rising Star in Research. Dr. Hartwell has published 20 peer-reviewed articles, 26 presentation abstracts and 4 patents. Dr. Hartwell holds a faculty position at UBC and is active managing teams and conducting research. As an active member of the academic and life sciences community, Dr. Hartwell continues to lecture for the UBC Department of Surgery, as well as to lead investigator-forums and workshops at major local, national and international conferences. Prior to receiving his Ph.D., Dr. Hartwell attended the University of Ottawa, graduating with honours in Biochemistry and shortly thereafter as conducting research in Free Radicals in Medicine at the National University of Singapore under world-renowned researcher and industry leader, Professor Barry Halliwell.